过去一年中添加的文章，按日期排序
Phase I trial of the multi-kinase inhibitor cabozantinib, a CYP3A4 substrate, plus CYP3A4-interacting antiretroviral therapy in people living with HIV and cancer (AMC …
M Haigentz Jr, JY Lee, EY Chiao, DM Aboulafia… - Clinical Cancer …, 2023 - AACR
342 天前 - … Ritonavir and cobicistat are strong CYP3A4 inhibitors … study was the durable
activity of cabozantinib in PLWH and Kaposi sarcoma as well as follicular dendritic cell sarcoma …
activity of cabozantinib in PLWH and Kaposi sarcoma as well as follicular dendritic cell sarcoma …